R&G PharmaStudies
China clinical CRO with biometrics and trial management capabilities. A Medidata partnership announcement supports its clinical technology and data-standardization approach; confirm international sponsor references and IIT staffing directly.
Corporate information
- Company entity
- R&G PharmaStudies
- Headquarters / principal office
- China-based / China-origin platform ↗
- Founded
- Not verified in this review
- Ownership / capital status
- Not verifiedSee entity-specific disclosures; group figures are not clinical revenue
- Official corporate reference
- https://www.medidata.com/cn/about-us/news-and-press/rgps-expands-partnership-with-medidata-deploying-the-medidata-data-experience/ ↗
- LinkedIn company page
- Independent company page not verified
Profile review: 2026-11-06 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Public evidence snapshot
China clinical CRO with biometrics and trial management capabilities. A Medidata partnership announcement supports its clinical technology and data-standardization approach; confirm international sponsor references and IIT staffing directly.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.
Original sources
- R&G PharmaStudies — Official clinical services / corporate disclosure
- R&G PharmaStudies — Official clinical services / corporate disclosure